Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Respiratory Investigation
|
January 10, 2026
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial
Kozo Morimoto, James D Chalmers, Pierre-Régis Burgel, et al.
Iscience
|
March 5, 2025
A microfluidic platform for anterior-posterior human endoderm patterning via countervailing morphogen gradients <i>in vitro</i>
Leeya Engel, Kevin J Liu, Kiara W Cui, et al.
Environmental Health Perspectives
|
April 16, 2016
Effects of Acute Low-Dose Exposure to the Chlorinated Flame Retardant Dechlorane 602 and Th1 and Th2 Immune Responses in Adult Male Mice
Yu Feng, Jijing Tian, Heidi Qunhui Xie, et al.
Analytical Chemistry
|
January 6, 2022
High-Throughput Kinetic Characterization of Irreversible Covalent Inhibitors of KRAS<sup>G12C</sup> by Intact Protein MS and Targeted MRM
Ke Sherry Li, John G Quinn, Matthew J Saabye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2018
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study
Daniel J George, Jean-François Martini, Michael Staehler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2018
Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Daniel J George, Jean-Francois Martini, Michael Staehler, et al.
STAR Protocols
|
December 20, 2024
Protocol for efficient generation of human artery and vein endothelial cells from pluripotent stem cells
Kyle M Loh, Sherry Li Zheng, Kevin J Liu, et al.
European Journal of Pharmacology
|
February 8, 2012
Salidroside stimulates the accumulation of HIF-1α protein resulted in the induction of EPO expression: a signaling via blocking the degradation pathway in kidney and liver cells
Ken Yu-Zhong Zheng, Zhen-Xia Zhang, Ava Jiang-Yang Guo, et al.
The Lancet. Oncology
|
November 1, 2019
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial
Alice T Shaw, Benjamin J Solomon, Rita Chiari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 2019
<i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
Alice T Shaw, Benjamin J Solomon, Benjamin Besse, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Respiratory Investigation
|
January 10, 2026
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial
Kozo Morimoto, James D Chalmers, Pierre-Régis Burgel, et al.
Iscience
|
March 5, 2025
A microfluidic platform for anterior-posterior human endoderm patterning via countervailing morphogen gradients <i>in vitro</i>
Leeya Engel, Kevin J Liu, Kiara W Cui, et al.
Environmental Health Perspectives
|
April 16, 2016
Effects of Acute Low-Dose Exposure to the Chlorinated Flame Retardant Dechlorane 602 and Th1 and Th2 Immune Responses in Adult Male Mice
Yu Feng, Jijing Tian, Heidi Qunhui Xie, et al.
Analytical Chemistry
|
January 6, 2022
High-Throughput Kinetic Characterization of Irreversible Covalent Inhibitors of KRAS<sup>G12C</sup> by Intact Protein MS and Targeted MRM
Ke Sherry Li, John G Quinn, Matthew J Saabye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2018
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study
Daniel J George, Jean-François Martini, Michael Staehler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2018
Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Daniel J George, Jean-Francois Martini, Michael Staehler, et al.
STAR Protocols
|
December 20, 2024
Protocol for efficient generation of human artery and vein endothelial cells from pluripotent stem cells
Kyle M Loh, Sherry Li Zheng, Kevin J Liu, et al.
European Journal of Pharmacology
|
February 8, 2012
Salidroside stimulates the accumulation of HIF-1α protein resulted in the induction of EPO expression: a signaling via blocking the degradation pathway in kidney and liver cells
Ken Yu-Zhong Zheng, Zhen-Xia Zhang, Ava Jiang-Yang Guo, et al.
The Lancet. Oncology
|
November 1, 2019
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial
Alice T Shaw, Benjamin J Solomon, Rita Chiari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 2019
<i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
Alice T Shaw, Benjamin J Solomon, Benjamin Besse, et al.
Page
of 5